PL365072A1 - Azole compounds as therapeutic agents for fungal infections - Google Patents
Azole compounds as therapeutic agents for fungal infectionsInfo
- Publication number
- PL365072A1 PL365072A1 PL01365072A PL36507201A PL365072A1 PL 365072 A1 PL365072 A1 PL 365072A1 PL 01365072 A PL01365072 A PL 01365072A PL 36507201 A PL36507201 A PL 36507201A PL 365072 A1 PL365072 A1 PL 365072A1
- Authority
- PL
- Poland
- Prior art keywords
- therapeutic agents
- fungal infections
- azole compounds
- azole
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN198DE2000 IN191188B (en) | 2000-03-07 | 2000-03-07 | |
| US09/575,578 US6670363B1 (en) | 2000-03-07 | 2000-05-22 | Azole compounds as therapeutic agents for fungal infections |
| PCT/IB2001/000300 WO2001066551A2 (en) | 2000-03-07 | 2001-03-01 | Azole compounds as therapeutic agents for fungal infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL365072A1 true PL365072A1 (en) | 2004-12-27 |
Family
ID=26324879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01365072A PL365072A1 (en) | 2000-03-07 | 2001-03-01 | Azole compounds as therapeutic agents for fungal infections |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1278755A2 (en) |
| JP (1) | JP2004501867A (en) |
| AU (1) | AU3402301A (en) |
| CA (1) | CA2402345A1 (en) |
| NZ (1) | NZ521241A (en) |
| PL (1) | PL365072A1 (en) |
| RU (1) | RU2002126272A (en) |
| WO (1) | WO2001066551A2 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002218505A1 (en) * | 2000-11-30 | 2002-06-11 | Senju Pharmaceutical Co. Ltd. | Pancreatitis remedies and medicines for prevention and therapy of reflux esophagitis |
| MXPA03005899A (en) | 2000-12-26 | 2004-01-26 | Ranbaxy Lab Ltd | Azole compounds as anti-fungals agents. |
| EP1356816B1 (en) | 2001-01-29 | 2009-12-23 | Shionogi & Co., Ltd. | Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| HUP0303249A3 (en) | 2001-02-22 | 2007-03-28 | Sankyo Co | Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them |
| IN192526B (en) * | 2001-09-25 | 2004-04-24 | Ranbaxy Lab | |
| AU2002328176A1 (en) * | 2002-08-26 | 2004-03-11 | Ranbaxy Laboratories Limited | Azole derivatives as antifungal agents |
| EP1413301A1 (en) * | 2002-10-24 | 2004-04-28 | Bayer CropScience SA | Antifungal medicaments comprising arylamidine derivatives |
| WO2007020888A1 (en) | 2005-08-12 | 2007-02-22 | Takeda Pharmaceutical Company Limited | Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| EP2709609B1 (en) | 2011-05-17 | 2017-10-04 | Shionogi & Co., Ltd. | Heterocyclic compounds |
| EA032840B8 (en) | 2011-06-22 | 2020-06-18 | Вайоми Терапеутикс Лимитед | Conjugate-based antifungal prodrugs and use thereof |
| CN102617494B (en) * | 2012-03-15 | 2014-10-29 | 南京工业大学 | Triazole compounds containing olefine ether structure, and preparation method and application thereof |
| MX2015016675A (en) | 2013-06-04 | 2016-07-15 | Vyome Biosciences Pvt Ltd | Coated particles and compositions comprising same. |
| US10071103B2 (en) | 2014-01-29 | 2018-09-11 | Vyome Biosciennces Pvt. Ltd. | Treatments for resistant acne |
| CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
| WO2018060070A1 (en) | 2016-09-29 | 2018-04-05 | Bayer Cropscience Aktiengesellschaft | Novel triazole derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW218017B (en) * | 1992-04-28 | 1993-12-21 | Takeda Pharm Industry Co Ltd | |
| CA2134417A1 (en) * | 1993-12-22 | 1995-06-23 | Katsumi Itoh | Optically active azole derivatives, their production and use |
| US5639754A (en) * | 1994-07-12 | 1997-06-17 | Janssen Pharmaceutica N.V. | Urea and thiourea derivatives of azolones |
| EP0957101A1 (en) * | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
-
2001
- 2001-03-01 EP EP01906061A patent/EP1278755A2/en not_active Withdrawn
- 2001-03-01 CA CA002402345A patent/CA2402345A1/en not_active Abandoned
- 2001-03-01 JP JP2001565367A patent/JP2004501867A/en active Pending
- 2001-03-01 RU RU2002126272/04A patent/RU2002126272A/en not_active Application Discontinuation
- 2001-03-01 WO PCT/IB2001/000300 patent/WO2001066551A2/en not_active Application Discontinuation
- 2001-03-01 PL PL01365072A patent/PL365072A1/en not_active Application Discontinuation
- 2001-03-01 NZ NZ521241A patent/NZ521241A/en unknown
- 2001-03-01 AU AU34023/01A patent/AU3402301A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1278755A2 (en) | 2003-01-29 |
| RU2002126272A (en) | 2004-08-10 |
| WO2001066551A8 (en) | 2003-06-26 |
| WO2001066551A2 (en) | 2001-09-13 |
| WO2001066551A3 (en) | 2002-03-07 |
| NZ521241A (en) | 2004-02-27 |
| CA2402345A1 (en) | 2001-09-13 |
| JP2004501867A (en) | 2004-01-22 |
| AU3402301A (en) | 2001-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002221239A1 (en) | Therapeutic benzimidazole compounds | |
| HK1102915A1 (en) | Endoparasiticidal agents for topical application | |
| EP1387680A4 (en) | Benzimidazole derivatives as therapeutic agents | |
| HK1057702A1 (en) | Triazole compounds useful as protein kinase inhibitors | |
| AU2001230426A1 (en) | Therapeutic morpholino-substituted compounds | |
| IL148719A0 (en) | Kinase inhibitors as therapeutic agents | |
| PL365134A1 (en) | Imidazole derivatives | |
| EP1432420A4 (en) | Benzimidazolidinone derivatives as muscarinic agents | |
| HK1075619A1 (en) | New uses for anti-malarial therapeutic agents | |
| IL159742A0 (en) | Azole derivatives useful as insecticide | |
| PL365072A1 (en) | Azole compounds as therapeutic agents for fungal infections | |
| AU2002328176A1 (en) | Azole derivatives as antifungal agents | |
| GB0118407D0 (en) | Oxazolidinone derivatives as antibacterial agents | |
| GB0105893D0 (en) | Pharmaceutically active compounds | |
| GB0107751D0 (en) | Pharmaceutically active compounds | |
| AU2002253456A8 (en) | Azole derivatives as antifungal agents | |
| IL154258A0 (en) | Fungicidal formulation | |
| GB0106631D0 (en) | Pharmaceutically active compounds | |
| SI1261588T1 (en) | IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS | |
| AU2003258983A8 (en) | Combinations for the treatment of fungal infections | |
| AU2001262729A1 (en) | 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds | |
| PL362051A1 (en) | Azole compounds as anti-fungals agents | |
| EP1412337A4 (en) | Azole compounds as anti-fungal agents | |
| AUPQ515700A0 (en) | Imidazole compounds | |
| GB2360705B (en) | Anti fungal formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |